Granted Patent
B2
US 8,283,372 · App. 12/819,221 · Granted Oct 9, 2012
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
Assignee:
TetraLogic Pharmaceuticals Corp.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A SMAC mimetic and pharmaceutical compositions thereof and methods of use.
Claims (6)
1. A compound having the formula:
wherein R5 is —CH2CH3, or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising the compound having the formula:
wherein R5 is —CH2CH3, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.
3. The pharmaceutical composition of claim 2 is a sterile liquid for injection.
4. The pharmaceutical composition of claim 2 is a unit dose form.
Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED AT REEL: 047436 FRAME: 0203. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Recorded May 25, 2021
From: TETRALOGIC BIRINAPANT UK LTD.
To: MEDIVIR AB
Reel/Frame 056392/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 7, 2018
From: TETRALOGIC BIRINAPANT UK
To: MEDIVIR AB
Reel/Frame 047436/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 6, 2015
From: TETRALOGIC PHARMACEUTICALS CORPORATION
To: TETRALOGIC BIRINAPANT UK LTD
Reel/Frame 036264/0713 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 23, 2010
From: CONDON, STEPHEN M; DENG, YIJUN; LAPORTE, MATTHEW G; RIPPIN, SUSAN R
To: TETRALOGIC PHARMACEUTICALS CORP.
Reel/Frame 024579/0561 →
Continuity (2)
Provisional Application
61222668
· Jul 2, 2009